First Trust Nasdaq Pharmaceuticals ETF
FTXH
8 hedge funds and large institutions have $1.16M invested in First Trust Nasdaq Pharmaceuticals ETF in 2019 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 0 increasing their positions, 3 reducing their positions, and 1 closing their positions.
200% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 1
33% more funds holding
Funds holding: 6 → 8 (+2)
21% more capital invested
Capital invested by funds: $958K → $1.16M (+$201K)
3.25% less ownership
Funds ownership: 24.95% → 21.7% (-3.3%)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$552K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$31.2K |
| 3 |
AG
Advisor Group
Phoenix,
Arizona
|
+$14.6K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
-$484K |
| 2 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$11.6K |
| 3 |
Bank of America
Charlotte,
North Carolina
|
-$10.4K |
| 4 |
CA
Claro Advisors
Boston,
Massachusetts
|
-$2K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $568K | +$552K | +26,559 | New |
|
|
2
Jane Street
New York
| $301K | -$484K | -23,277 | -62% |
|
|
SMFS
3
Squar Milner Financial Services
Irvine,
California
| $120K | – | – | – |
|
|
4
Royal Bank of Canada
Toronto,
Ontario, Canada
| $64K | -$11.6K | -557 | -16% |
|
|
5
Bank of America
Charlotte,
North Carolina
| $45K | -$10.4K | -500 | -19% |
|
|
6
UBS Group
Zurich,
Switzerland
| $32K | +$31.2K | +1,502 | New |
|
|
AG
7
Advisor Group
Phoenix,
Arizona
| $15K | +$14.6K | +700 | New |
|
|
LTFS
8
Ladenburg Thalmann Financial Services
Miami,
Florida
| $14K | – | – | – |
|
|
CA
9
Claro Advisors
Boston,
Massachusetts
| – | -$2K | -84 | Closed |
|
FTXH Hedge Fund Activity: Q1 2019 in Review
8 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in First Trust Nasdaq Pharmaceuticals ETF (FTXH) for Q1 2019, worth a combined $1.16M — up 21% from $958K a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new FTXH positions and 1 closed out — a net gain of 2 holders — while 0 added to existing stakes and 3 trimmed.
The largest buyer was Susquehanna International Group, opening a new position worth an estimated $552K. The largest seller was Jane Street, cutting an estimated $484K.
- 8 institutional investors held First Trust Nasdaq Pharmaceuticals ETF (FTXH) as of Q1 2019, up from 6 in Q4 2018.
- Funds reported $1.16M of First Trust Nasdaq Pharmaceuticals ETF stock for Q1 2019, up 21% quarter-over-quarter.
- 3 funds opened new First Trust Nasdaq Pharmaceuticals ETF positions in Q1 2019 and 1 closed out, a net change of +2 holders.
- The largest First Trust Nasdaq Pharmaceuticals ETF buyer in Q1 2019 was Susquehanna International Group, an estimated $552K added.
- The largest First Trust Nasdaq Pharmaceuticals ETF seller in Q1 2019 was Jane Street, an estimated $484K sold.
Based on aggregated 13F filings for Q1 2019.